Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 25, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
Life Sciences Times
-
November 15, 2024
Pharma
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Life Sciences Times
-
November 7, 2024
Pharma
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
Life Sciences Times
-
October 30, 2024
Pharma
Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint
Life Sciences Times
-
October 30, 2024
Pharma
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Life Sciences Times
-
October 15, 2024
Pharma
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma
Life Sciences Times
-
January 5, 2023
0
Pharma
PharmaEssentia Establishes a New Research and Development Facility in the Boston Area
Life Sciences Times
-
January 4, 2023
0
Pharma
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Life Sciences Times
-
January 3, 2023
0
Pharma
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
Life Sciences Times
-
December 22, 2022
0
Pharma
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Life Sciences Times
-
December 21, 2022
0
Pharma
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Life Sciences Times
-
December 21, 2022
0
Pharma
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or...
Life Sciences Times
-
December 20, 2022
0
Pharma
Massachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic...
Life Sciences Times
-
December 16, 2022
0
Pharma
Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension
Life Sciences Times
-
December 15, 2022
0
Pharma
Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol
Life Sciences Times
-
December 14, 2022
0
Pharma
Lantern Pharma Announces Development of Drug Candidate LP-184 for Triple Negative Breast Cancer (TNBC)
Life Sciences Times
-
December 13, 2022
0
Pharma
MTTI Obtains FDA Allowance of Investigational New Drug (IND) for Hürthle Cell Thyroid Cancer
Life Sciences Times
-
December 8, 2022
0
1
...
12
13
14
...
59
Page 13 of 59
Most Read
Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH
November 25, 2024
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
November 25, 2024
HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500
November 25, 2024
Inspira Health Announces Promotion of Julie H. Ellis, MBA, SHRM-SCP to Senior Vice President and Chief Human Resources Officer
November 22, 2024